COVID-19 Pandemic. Impact on Hysteroscopic Procedures: A Consensus Statement from the Global Congress of Hysteroscopy Scientific Committee

Carugno, Josè; Sardo, Attilio Di Spiezio; Alonso, Luis; Haimovich, Sergio; Campo, R. del; Angelis, C. De; Bradley, Linda D.; Bettocchi, Stefano; Arias, Alfonso Martínez; Isaacson, Keith; Okohue, Jude Ehiabhi; Farrugia, M.; Kumar, Alka; Xue, Xiang; Cavalcanti, Luiz Nazareno; Laganà, Antonio Simone; Grimbizis, Grigoris

doi:10.1016/j.jmig.2020.04.023

Cited by 30 publications

(38 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The first point is the recommendation to check COVID-19 infection in any patients referring to the hospital right after arrival (9). The consideration of this recommendation is necessary, as the clinical symptoms may not present during the incubation period and are not sufficient for diagnosis (3).…”

Section: Discussionmentioning

confidence: 99%

Disseminated Intravascular Coagulation as the First Manifestation of Coronavirus Disease: Report of a Survived Deadly Case

2020

ircmj

View full text Add to dashboard Cite

Introduction: Coronavirus disease 2019 (COVID-19), newly emerging in the world as a pandemic disease, can have rare extrapulmonary manifestations. Few studies have reported coagulation disorders, induced by coronavirus; however, hemorrhage is an extremely rare and life-threatening phenomenon in COVID-19. Case presentation: Herein, we present a 31-year-old woman referring with vaginal bleeding, melena, skin ecchymosis, mucosal bleeding, melena, hematuria, and hypovolemic shock. At our center, she was diagnosed as a case of severe internal hemorrhage due to ovulation site hemorrhage and underwent emergency surgery, complicated by prolonged international normalized ratio, which could be due to the presence of COVID-19 in the patient, detected by spiral computed tomography. Conclusions: This case showed the importance of examining COVID-19 in any patients referring to the hospital during the pandemic as well as paying greater attention to the effect of COVID-19 on coagulation disorders in these patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Disseminated Intravascular Coagulation as the First Manifestation of Coronavirus Disease: Report of a Survived Deadly Case

2020

ircmj

View full text Add to dashboard Cite

show abstract

“…The risk of viral transmission at time of hysteroscopy, particularly with bipolar electrosurgical devices and normal saline solution, is theoretically low given that it is not an aerosol‐generating procedure 11 . The “see and treat” approach in an outpatient setting is advisable 11 . Depending on hospital resources, it is reasonable to submit to outpatient office procedures patients with polyps and symptomatic myomas not responding to medical treatments.…”

Section: Surgical Management Of Gynecologic Diseasesmentioning

confidence: 99%

Practical recommendations for gynecologic surgery during the COVID‐19 pandemic

Chiofalo¹,

Baiocco²,

Mancini³

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Surgery in suspected/confirmed COVID‐19 patients is a high‐risk venture. In infected patients, COVID‐19 is present in the body cavity. During surgery it could be nebulized in the spray generated by surgical instruments and could theoretically infect members of the surgical team. Nevertheless, some surgical gynecologic pathologies cannot be postponed. We present a list of the most frequent gynecologic diseases and recommendations on their surgical management during the COVID‐19 pandemic, based on expert opinion, current available information, and international scientific society recommendations to support the work of gynecologists worldwide. In brief, any kind of surgical treatment should be scrutinized and postponed if possible. Nonoperative conservative treatment including pharmacological therapies for hormone‐sensitive pathologies should be implemented. Health risk assessment by patient history and COVID‐19 test before elective surgery are pivotal to protect both patients and healthcare providers. In confirmed COVID‐19 patients or highly suspected cases, elective surgery should be postponed until full recovery.

show abstract

“…Limit hysteroscopic procedures to COVID-19negative patients and to those patients in whom delaying the procedure could result in adverse clinical outcomes. 23 Universally screen for potential COVID-19 infection. When possible, a phone interview to triage patients based on their symptoms and infection exposure status should take place before the patient arrives to the health care center.…”

Section: Recommendations: Generalmentioning

confidence: 99%

Hysteroscopy and COVID-19: Have recommended techniques changed due to the pandemic?

Florez¹,

Carugno²

2020

OBGM

Self Cite

View full text Add to dashboard Cite

COVID-19 Pandemic. Impact on Hysteroscopic Procedures: A Consensus Statement from the Global Congress of Hysteroscopy Scientific Committee

Cited by 30 publications

References 16 publications

Disseminated Intravascular Coagulation as the First Manifestation of Coronavirus Disease: Report of a Survived Deadly Case

Disseminated Intravascular Coagulation as the First Manifestation of Coronavirus Disease: Report of a Survived Deadly Case

Practical recommendations for gynecologic surgery during the COVID‐19 pandemic

Hysteroscopy and COVID-19: Have recommended techniques changed due to the pandemic?

Contact Info

Product

Resources

About